This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Charles J. Grossman, PhD

JAMA. 1990;264(8):1028.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the last decade there has been an unfortunate reappearance in our society of an antitechnology and antiscience attitude. This is exemplified by those advocates who would ban all animals in research and block fetal tissue studies and by those who support creationism. An especially vocal group consists of those people who are against any form of genetic engineering regardless of the benefits or potential benefits that might be realized.

We can find no better example of the genetic engineering controversy than that epitomized by the furor currently surrounding the use of bovine somatotropin (growth hormone) in dairy cows. Manufactured by Monsanto, American Cyanamid, Eli Lilly, and Upjohn, the drug will not become commercially available until the end of 1990 when Food and Drug Administration approval is expected.^1-3 However, it has been extensively studied for the past 5 years and can clearly increase milk production by at least 14%. . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Veterans Affairs Medical Center, Research Service; the Department of Physiology and Biophysics, the College of Medicine, University of Cincinnati; and the Department of Biology, Xavier University, Cincinnati, Ohio.

Footnotes
Reprint requests to Department of Veterans Affairs Medical Center, 3200 Vine St, Cincinnati, OH 45220 (Dr Grossman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?